Product Information
TADALAFIL 20 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1922 per EA under NDC 47335001283. Its NADAC has been published 355 times since May 8, 2019.
FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335001283
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA208934FDA Approved
3/26/2019
TE Code
AB1
On Market Since
3/26/2019
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 20 MG TABLET has been published 355 times since May 8, 2019, and over the history we have for it it has declined 99.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1922 per EA |
|---|---|
| All-time high | $46.3981 (Jun 12, 2019) |
| All-time low | $0.1568 (Nov 20, 2024) |
| 52-week high | $0.2171 |
| 52-week low | $0.1922 |
| Median price | $0.3656 |
| Average price | $1.1768 |
| Largest weekly change | -98.1% (Jun 19, 2019) |
| Weeks tracked | 355 |
| Tracking since | May 8, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-11.5%
3Y
-39.5%
5Y
-56.1%
All
-99.6%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1922 per EA (NDC 47335001283), effective Feb 18, 2026.
How has the price of TADALAFIL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 99.6%. It has been tracked across 355 weekly CMS publications since May 8, 2019.
What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?
Since May 8, 2019, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1568 (Nov 20, 2024) to a high of $46.3981 (Jun 12, 2019), with a median of $0.3656 per EA.
Are there cheaper alternatives to TADALAFIL 20 MG TABLET?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYQ 20 MG TABLET, is $0.1400 per EA — about 27% below TADALAFIL 20 MG TABLET.
Who manufactures TADALAFIL 20 MG TABLET?
TADALAFIL 20 MG TABLET (NDC 47335001283) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.